In the healthy adult brain synapses are continuously remodelled through a process of elimination and formation known as structural plasticity 1 . Reduction in synapse number is a consistent early feature of neurodegenerative diseases 2,3 , suggesting deficient compensatory mechanisms. Although much is known about toxic processes leading to synaptic dysfunction and loss in these disorders 2,3 , how synaptic regeneration is affected is unknown. In hibernating mammals, cooling induces loss of synaptic contacts, which are reformed on rewarming, a form of structural plasticity 4,5 . We have found that similar changes occur in artificially cooled laboratory rodents. Cooling and hibernation also induce a number of cold-shock proteins in the brain, including the RNA binding protein, RBM3 (ref. 6). The relationship of such proteins to structural plasticity is unknown. Here we show that synapse regeneration is impaired in mouse models of neurodegenerative disease, in association with the failure to induce RBM3. In both prion-infected and 5XFAD (Alzheimer-type) mice 7 , the capacity to regenerate synapses after cooling declined in parallel with the loss of induction of RBM3. Enhanced expression of RBM3 in the hippocampus prevented this deficit and restored the capacity for synapse reassembly after cooling. RBM3 overexpression, achieved either by boosting endogenous levels through hypothermia before the loss of the RBM3 response or by lentiviral delivery, resulted in sustained synaptic protection in 5XFAD mice and throughout the course of prion disease, preventing behavioural deficits and neuronal loss and significantly prolonging survival. In contrast, knockdown of RBM3 exacerbated synapse loss in both models and accelerated disease and prevented the neuroprotective effects of cooling. Thus, deficient synapse regeneration, mediated at least in part by failure of the RBM3 stress response, contributes to synapse loss throughout the course of neurodegenerative disease. The data support enhancing cold-shock pathways as potential protective therapies in neurodegenerative disorders.
In the healthy adult brain synapses are continuously remodelled through a process of elimination and formation known as structural plasticity 1 . Reduction in synapse number is a consistent early feature of neurodegenerative diseases 2,3 , suggesting deficient compensatory mechanisms. Although much is known about toxic processes leading to synaptic dysfunction and loss in these disorders 2, 3 , how synaptic regeneration is affected is unknown. In hibernating mammals, cooling induces loss of synaptic contacts, which are reformed on rewarming, a form of structural plasticity 4, 5 . We have found that similar changes occur in artificially cooled laboratory rodents. Cooling and hibernation also induce a number of cold-shock proteins in the brain, including the RNA binding protein, RBM3 (ref. 6 ). The relationship of such proteins to structural plasticity is unknown. Here we show that synapse regeneration is impaired in mouse models of neurodegenerative disease, in association with the failure to induce RBM3. In both prion-infected and 5XFAD (Alzheimer-type) mice 7 , the capacity to regenerate synapses after cooling declined in parallel with the loss of induction of RBM3. Enhanced expression of RBM3 in the hippocampus prevented this deficit and restored the capacity for synapse reassembly after cooling. RBM3 overexpression, achieved either by boosting endogenous levels through hypothermia before the loss of the RBM3 response or by lentiviral delivery, resulted in sustained synaptic protection in 5XFAD mice and throughout the course of prion disease, preventing behavioural deficits and neuronal loss and significantly prolonging survival. In contrast, knockdown of RBM3 exacerbated synapse loss in both models and accelerated disease and prevented the neuroprotective effects of cooling. Thus, deficient synapse regeneration, mediated at least in part by failure of the RBM3 stress response, contributes to synapse loss throughout the course of neurodegenerative disease. The data support enhancing cold-shock pathways as potential protective therapies in neurodegenerative disorders.
We used the phenomenon of physiological structural plasticity seen in hibernating mammals to determine the capacity for synapse regeneration in mouse models of neurodegenerative disease. When they enter torpor, the neurons of hibernators undergo morphological changes including changes in spine morphology 8, 9 and/or changes in connectivity 4, 5 . These are rapidly reversed on regaining normal body temperature 4, 5, [8] [9] [10] . We first established that the phenomenon of synapse dismantling and reassembly (structural plasticity) on artificial cooling and rewarming occurs in laboratory mice ( Fig. 1a and Extended Data Fig. 1a ). We then explored the capacity for structural plasticity after cooling in two mouse models of neurodegenerative disease: prion disease and the 5XFAD model of Alzheimer's disease 7 . We used tg37 1/2 mice 11 infected with Rocky Mountain Laboratory (RML) prions used in our previous studies [12] [13] [14] . These mice show substantial synapse loss from 7 weeks post-inoculation 1 Representative electron micrographs (pseudo-coloured for ease of synapse identification: yellow, presynaptic; green, postsynaptic compartments) and bar charts showing quantification are shown for each experiment (n 5 4 animals at 18 uC and n 5 2 at 37 uC; 192 images from 2 mice per condition for 3D analyses; 93 images from 3 animals per condition, for 2D analyses). A typical tripartite synapse is shown at higher magnification. b, c, The same response is seen in prion-diseased mice (b) at 4 and 5 w.p.i. but this fails at 6 w.p.i (arrow), and in 5XFAD (c) mice, where it fails at 3 months (arrow). ***P , 0.0001, **P , 0.01; NS, not significant. Student's t-test; two tailed. All data in bar charts are mean 6 s.e.m. Scale bar, 1 mm. Source Data for all figures can be found in the Supplementary Tables. (w.p.i.) 13 ; 5XFAD mice have synapse loss from 4 months, after which time learning deficits emerge 7 . We tested the capacity for structural plasticity using cooling early in the course of disease, before the onset of established synapse loss in both models: from 4 w.p.i. in prion-infected animals and from 2 months of age in 5XFAD mice.
All mice were cooled to 16-18 uC for 45 min, similar to core temperatures reached in small hibernators (deep hypothermia) using the biomolecule 59-adenosine monophosphate (59-AMP) 15 , after which they were allowed to slowly rewarm. Animals were euthanized at each stage of the cooling-rewarming process and synapses were counted in the CA1 region of hippocampus. Both synapse density and total synapse number significantly declined on cooling, but recovered on rewarming in wild-type mice, as measured using both three dimensional (3D) 16 and two dimensional (2D) analyses 13 (Fig. 1a ). Neither brain volume nor synapse size changed on cooling and rewarming, excluding the possibility that changes in synapse density reflected changes in these parameters (Extended Data Fig. 1a ). Thus, wild-type mice showed synaptic structural plasticity with reduction in synapse number on cooling and recovery on rewarming ( Fig. 1a ). This capacity for plasticity was also seen in both prion-infected and 5XFAD mice very early in the course of disease, at 4 and 5 w.p.i., and at 2 months of age, respectively (Fig. 1b, c) . However, this capacity was lost by 6 w.p.i. in prion-diseased mice ( Fig. 1b and Extended Data Fig. 1b ) and at 3 months in 5XFAD mice ( Fig. 1c and Extended Data Fig. 1c ). Notably, impaired structural plasticity shortly preceded established decline in synapse number seen in prion-infected tg37 1/2 mice at 7 w.p.i. (ref. 14) , and in the 5XFAD mice from 4 months of age (see schematic, Extended Data Fig. 1d ). The lost ability to reassemble synapses was not due to loss of synaptic proteins at this stage (Extended Data striking reduction in hippocampal spongiosis and protection of CA1 neurons (bar chart) in cooled mice that is abolished by RBM3 knockdown (n 5 4-6 animals per treatment, except LV-shRNA-RBM3: n 5 2). Scale bar, 50 mm. One-way ANOVA, Brown-Forsythe test with Tukey's post hoc analysis for multiple comparisons was used in d and e. f, Early cooling significantly prolonged survival, but this was abolished by knockdown of RBM3 (n 5 31 cooled mice; n 5 17 not cooled; n 5 10 cooled 1 RNAi of RBM3). Mann-Whitney U-test. *P , 0.05; **P , 0.01; ***P , 0.001. Two-tailed Student's t-test was used unless otherwise stated. All data in bar charts are mean 6 s.e.m.
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prion protein (PrP Sc ) in prion-infected mice, or of amyloid-b oligomers in 5XFAD mice induced by the cooling-rewarming process (Extended Data Fig. 3 ).
In hibernation and hypothermia, global protein synthesis and cell metabolism are downregulated, but low temperature also induces a small subset of proteins known as cold-shock proteins that escape translational repression 17, 18 . Amongst these, RNA-binding motif protein 3 (RBM3) and cold-inducible RNA binding protein (CIRP, also known as CIRBP) are cold-shock proteins expressed at high levels in brain 6, 19 . We found strong induction of RBM3 by cooling in brains of wild-type mice and in mice with prion disease at 4 w.p.i. and 5XFAD mice at 2 months ( Fig. 2 ). CIRP was not upregulated (Extended Data Fig. 4 ). However, both prion and 5XFAD mice lost the capacity to upregulate RBM3 after cooling at 6 w.p.i. (Fig. 2b ) and at 3 months of age ( Fig. 2c ), respectively, in parallel with the lost ability to reassemble synapses after cooling at these time points (Fig. 1b, c) . Therefore, we asked if induction of RBM3 expression drives synaptic recovery.
Therapeutic hypothermia is a powerful neuroprotectant in brain injury acting through multiple mechanisms, including enhanced gene expression driving regenerative processes enhancing synapse formation (see ref. 17 for a review). RBM3 has been implicated in protection against cell death in various in vitro models of cooling and neuroprotection 20, 21 , albeit in conditions of mild hypothermia (,32 uC). It is known to increase local protein synthesis at dendrites 19 and global protein synthesis through ribosomal subunit binding and/or microRNA biogenesis 22 . The neuroprotective effects of hypothermia on neurodegenerative disease are unknown, however. Given that the capacity for structural plasticity correlated with induction of RBM3, we asked if raising endogenous RBM3 levels through early therapeutic cooling would restore failed synaptic plasticity. In wild-type mice, a single episode of cooling to 16-18 uC raised RBM3 levels in brain for up to 3 days (see Fig. 2a and Extended Data Fig. 4c ), suggesting the response is sustained for some time after the cold stress. Animals were cooled twice: at 3 w.p.i. and again at 4 w.p.i., resulting in a sustained several-fold increase in RBM3 expression up to 6 weeks later, declining to baseline levels at 12 w.p.i., at the terminal stage of disease ( Fig. 3a and Extended Data Fig. 5 ). Control mice were infected with prions but were not cooled. Early cooling and associated increased RBM3 expression protected against synapse loss in prion disease at 7, 8 and 9 w.p.i. (Fig. 3b ), restored synaptic transmission ( Fig. 3c ) and prevented behavioural deficits, maintaining burrowing behaviours and novel object recognition memory ( Fig. 3d and Extended Data Fig. 6a ). There was also marked neuronal protection in the hippocampus (Fig. 3e , compare subpanels ii and iii), even in mice succumbing to prion infection, which is ultimately overwhelming due to other toxic effects 13 . Most remarkably, early cooling significantly increased survival in prion-infected mice (91 6 7 days in cooled mice vs 84 6 4 days for uncooled mice; P 5 0.0002). Indeed, one animal survived 117 days post-infection, nearly a 50% increase in life expectancy ( Fig. 3f ). Mice cooled later in prion disease, at 5 and 6 w.p.i., when the RBM3 induction response is lost (see Fig. 2b ), did not show increased survival (Extended Data Fig. 7 ). As predicted, RBM3 knockdown by lentivirally mediated RNA interference (RNAi) in the hippocampus abolished the protective effects of early cooling on CA1 pyramidal neurons and spongiform change ( Fig. 3e , subpanel iv), on object recognition memory (Extended Data Fig. 6b , c), and on survival ( Fig. 3f ). As before, misfolded PrP levels were not affected by cooling (Extended Data Fig. 8 ). In therapeutic human hypothermia, temperatures of ,34 uC are used, similar to those of hibernating large mammals such as bears, which are known to induce similar transcriptional changes in RBM3 (ref. 6) . Therefore, these physiological changes in small rodents at 16-18 uC may well be relevant in therapeutic 
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human hypothermia 23 . Cooling of mice to higher core temperature of 26-28 uC, was similarly protective in prion disease, extending survival (Extended Data Fig. 9 ).
We next asked if RBM3 overexpression alone, in the absence of cooling, was similarly neuroprotective. We overexpressed, or knocked-down, RBM3 in both hippocampi of mice by stereotaxic injection of lentiviruses LV-RBM3 and LV-shRNA-RBM3, respectively. LV-RBM3 produced a threefold increase in RBM3 levels compared to controls up to 8 weeks post-injection; whereas knockdown by LV-shRNA-RBM3 reduced RBM3 levels to 30% of control levels (Fig. 4a ). LV-RBM3 treatment, but not LV-control, rescued the early deficit in synapse reassembly in both prion-infected and 5XFAD mice at 6 w.p.i. and 3 months, respectively ( Fig. 4b ). Furthermore, LV-RBM3 was associated with marked, sustained neuroprotective effects in prion-infected mice: preventing synapse loss ( Fig. 4c ), synaptic transmission decline ( Fig. 4d ) and memory and behavioural impairments (Fig. 4e ). In vitro, RBM3 has been shown to promote translation 22 . Increased global protein synthesis rates are profoundly neuroprotective, rescuing synapse number in prion disease 13, 14 . We found that RBM3 overexpression rescued levels of global translation, whereas RBM3 knockdown further reduced them, in prion-infected mice at 9 w.p.i. (Fig. 4f ) suggesting that this action of RBM3 along with preferential translation of specific RBM3-bound mRNAs, contributes to the synapse regeneration process. LV-RBM3 treatment reduced prion neuropathology and prevented neuronal loss (compare subpanels ii and iii in Fig. 4g ) and significantly extended survival of prion-infected animals (Fig. 4h ). This was not associated with changes in levels of PrP Sc , which were not affected by overexpression of RBM3 (Extended Data Fig. 8 ). Knockdown of RBM3, in contrast, accelerated synapse loss and memory and behavioural deficits ( Fig. 4c-e ), accelerating neuronal loss (Fig. 4g , subpanel iv) and significantly shortening survival (Fig. 4h ). 5XFAD mice do not allow similar examination of long-term effects of RBM3 overexpression as evolution of deficits and neuronal loss takes many months, and life expectancy is normal. However, RNAi of RBM3 accelerated onset of synaptic loss in 5XFAD mice, which was now seen at 3 months (Extended Data Fig. 10a ), suggesting that RBM3 has a long-term protective role in structural plasticity in these mice also. RBM3 knockdown also reduced synapse number and novel object memory in wild-type mice (Extended Data Fig. 10b ), thus it is likely to be involved in synaptic maintenance under normal physiological conditions.
In conclusion, we have shown that early synapse loss in mouse models of neurodegenerative disease results, at least in part, from defective synaptic repair processes associated with failure to induce the coldshock RNA-binding protein, RBM3. This results in impaired synaptic reassembly after cooling, but also appears to be important in the context of protecting against ongoing synaptic toxicity during disease, and in synaptic maintenance in wild-type mice. Our data suggest that further understanding the mechanisms of action of cold-shock proteins such as RBM3 may yield insights into endogenous repair processes and bring new therapeutic targets for neuroprotection in neurodegenerative disease.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Animals. All animal work conformed to UK regulations and institutional guidelines and were performed under UK Home Office guidelines. Prion infection of mice. The 3-week-old tg37 1/2 mice 11 were inoculated intracerebrally into the right parietal lobe with 30 ml of 1% brain homogenate of Chandler/ RML (Rocky Mountain Laboratories) prions under general anaesthetic, as described 24 . Animals were culled when they developed clinical signs of scrapie as defined in 14 .
Control mice received 1% normal brain homogenate. 5XFAD mice. Founder 5XFAD mice were obtained from the Jackson Laboratory (Ba Harbour, ME, USA). The 5XFAD mice have the following five mutations: Swedish (K670N and M671L), Florida (I716V) and London (V717I) in human APP695 and human PS1 cDNA (M146L and L286V) under the transcriptional control of the neuron-specific mouse Thy-1 promoter 7 . Colonies were maintained by crossing hemizygous transgenic to wild-type littermates. Induction of hypothermia. FVB, tg37 1/2 and 5XFAD mice weighing $ 20 g were cooled using 59-AMP as described 15, 25 , with slight modifications. Freshly prepared 59-AMP (Sigma) was injected intraperitoneally (0.7 mg per g). Control mice were injected with saline. Mice were maintained at room temperature until core body temperature decreased to 25 uC (approximately 60 min). Subsequently, mice were transferred to a refrigerator (5 uC) and core body temperature lowered to 16-18 uC for 45 min. Mice recovered normal body temperature at room temperature conditions. Cooled samples were collected at the end of the 16-18 uC period and rewarmed samples as stated elsewhere in the text. Electron microscopy data acquisition and analysis of synapse number. Male mice were used to avoid the effects on synapse number of the oestrus cycle. Brains were perfusion fixed with 2% glutaraldehyde 1 2% paraformaldehyde in 0.1 M sodium cacodylate buffer (final pH 7.3). Slices (300 mm) were prepared using a vibrating blade microtome (Leica Microsystems, Milton Keynes, UK). These slices were post-fixed in 1% osmium tetroxide 1 1% potassium ferrocyanide, stained enbloc with 5% uranyl acetate and embedded in epoxy resin (TAAB Laboratories Equipment Ltd, Aldermaston, UK), as described 26 .
For random sampling and calculation of synapse density, estimation of total synapse number and measures of volume of tissue using the stereology disector method, the following procedures were used, as described previously 16 . Fixed and stained slices were flat embedded as described 27 . The slices were mounted for microtomy, a semi-thin (1 mm) section was cut from the upper surface of each slice and the area of the stratum radiatum (sr) measured using the Cavalieri estimator (points grid), as described 16 . These results were then used to estimate the volume of the stratum radiatum and the systematic random selection of regions for electron microscopy, as described 16 . Briefly, the grid has intersections every 50 pixels (at a scale that 1 pixel is 1 mm). Each intersection was labelled with a dot. The dots were numbered in each of the sections generated per hippocampus. These numbers were used for measuring the area of each section and generate the data about the volume applying the following formula: VsrCA1 5 SPsrCA1 3 Ap 3 T (ref. 16 ). The total number of dots per hippocampus was divided by 6 (number of samples selected to obtain representative synapse variability from the whole hippocampus). The number obtained was used for the generation of a random number for sampling the first position and defined the interval for the subsequent 5 positions to be sampled. These regions were trimmed-down, mounted on aluminium pins and imaged by serial block-face scanning electron microscopy in a FEI Quanta FEG 250 electron microscope (FEI Ltd, Cambridge, UK) equipped with a '3View2XP' system (Gatan Ltd, Abingdon, UK). Images of 32 serial sections were generated in each of the six points. Serial sections of areas 51.4 mm 2 were recorded at 320,000 and an accelerating voltage of 3 kV, using spot size 3.0, at a working distance of 6.1 mm, and a dwell-time of 5 ms per pixel. The mean section thickness was estimated by sectioning only half of the original block face. The block was then reembedded, sectioned orthogonally and the depth removed by '3View' was measured by transmission electron microscopy 28 . The mean thickness of 3View sections was 86 nm. We analysed synapses in a volume stack of 88 mm 3 (with an area of 33 mm 2 , a measured section thickness of 0.086 mm and 31 sections). Synapses that had their first identifiable profile below the first section in the series were counted 16 . Synapses were identified, within a counting frame of 5.75 mm 3 5.75 mm, which follows the counting frame rules to avoid edge effect for the estimation of synapse numerical density. The total number of synapse was estimated with the synapse density and the volume of each hippocampus, as described 16 .
Synapse size was calculated by measuring mean synapse length, mean synapse area in the same serial sections used for estimations of synapse density and total synapse number, as described 16 .
For routine 2D analyses semi-thin (1 mm) sections were stained with toluidine blue and examined to select areas for ultramicrotomy. Ultrathin sections (,70 nm) were stained with lead citrate and examined, blind, in a Jeol 100-CXII electron microscope (JEOL (UK) Ltd, Welwyn Garden City, UK) equipped with a 'Megaview III' digital camera (Olympus Soft Imaging Solutions GmbH, Münster, Germany).
A series of images were recorded from the stratum radiatum, all at a distance of approximately 100 mm from the CA1 pyramidal layer to avoid the large dendritic profiles in the proximal area. 31 images, each encompassing an area of 55 mm 2 , from each of two to three mice were used for scoring. For synapse quantification the following criteria were followed: the presence of an unambiguous postsynaptic density, a clear synaptic cleft, and three or more synaptic vesicles. An average of 300 synapses were counted per sample. Quantifiation of numbers of neurons in CA1 region of hippocampus. For CA1 pyramidal layer volume analysis, whole hippocampus was cut and every 250 mm stained with haemotoxylin and eosin in fixed sections of 5 mm thickness. The volume of the pyramidal layer was measured using the Cavalieri estimator (points grid). For neuron mean density slices were stained with NeuN and calculated within an unbiased virtual space. The total number of neurons in CA1 pyramidal layer was estimated with the neuron density and the volume of the hippocampus. Immunoblotting. Protein samples were isolated from hippocampi using protein lysis buffer (50 mM Tris, 150 mM NaCl,1% Triton X-100, 1% Na deoxycholate, 0.1% SDS and 125 mM sucrose) supplemented with Phos-STOP and protease inhibitors (Complete, Roche), followed by centrifugation and quantification. Protein levels were determined by resolving 20 mg of protein on SDS-polyacrylamide gel electrophoresis gels, transferred onto either nitrocellulose or PDVF membranes and incubated with primary antibodies. Synaptic proteins were detected using the following antibodies: SNAP-25, (1:10,000; catalogue number: ab5666, Abcam), VAMP2 (1:5,000; catalogue number: 104204, Synaptic Systems), NMDA-R1 (1:1,000; catalogue number: G8913, Sigma) and PSD95 (1:1,000; catalogue number: 04-1066, Millipore). Odyssey IRDye800 secondary antibodies (1:5,000; catalogue number: 926-32210/32211 LI-COR) were applied, visualized and quantified using Odyssey infrared imager (LI-COR; software version 3.0). Protein for PrP levels was determined using the primary antibody ICSM35 (1:10,000; catalogue number: 0130-03501, D-GEN). PrP Sc was detected after Proteinase K digestion. Cold-shock protein levels were determined with antibodies CIRP (1:1,000; catalogue number: 10209-2-AP, Proteintech Group, Inc.) and RBM3 (1:500; catalogue number: 14363-1-AP, Proteintech Group, Inc.). Amyloid-b levels in 5XFAD mice were detected by 6E10 clone antibody (1:1,000; catalogue number: SIG-39320, Covanche). Horseradishperoxidase-conjugated secondary antibodies (1:10,000; DAKO) were applied and protein visualized using enhanced chemiluminescence (GE Healthcare) and quantified using ImageJ. An antibody against GAPDH (1:5,000; catalogue number: sc32233, Santa Cruz) was used to determine gel loading. Lentiviruses. GenTarget (San Diego, CA, USA) generated lentiviral plasmids. The neuron-specific promoter CAMKII was used to drive RBM3; the H1 promoter was used for shRNA-RBM3 expression and scrambled sequence-shRNA. Viruses were injected stereotaxically into the CA1 region of the hippocampus as described 29 .
Mouse RBM3 isoform 2 (NM_001166410.1) overexpression was induced using the pLentiCAMKII (RBM3)Rsv (GFPBsd) plasmid. pLentiCAMKII (empty)Rsv (GFPBsd) was used as control. RBM3 down regulation was achieved by using pLentiH1shRNA(m RBM3) sequence number 2Rsv(GFPBsd). This plasmid contains the following shRNA-RBM3 sense, anti-sense and loop sequences (sequence number 2: 59-GTTGATCATGCAGGAAAGTCTcgagAGACTTTCCTGCATGA TCAAC-39).
pLentyH1shRNA (negative control)Rsv (GFPBsd) containing the sequence 59-GTCTCCACGCGCAGTACATTT-39 was used as control. Lentiviral sequences and viral stocks were generated by GenTarget (San Diego, CA, USA). Virus titre was determined using FACS (BD FACS Calibur). Viruses were used with a final titre of 0.6 3 10 8 to 1.5 3 10 8 transducing units. Stereotaxic injection. Under general anaesthetic, mice were injected with 5 ml of lentivirus per site into the CA1 region of the hippocampus. Mice were injected at 2 locations per hemisphere; at 22 mm and 22.7 mm posterior, 6 2 mm lateral and 22.2 mm ventral relative to bregma, using a 26 s-gauge needle and Hamilton syringe as described 29 . Burrowing assay. This was performed as described 14, 30 . Briefly, mice were placed in individual large plastic cages containing a clear Perspex tube, 20 cm long 3 6.8 cm diameter, filled with 140 g of normal food pellets. The weight of pellets remaining in the tube was measured after 2 h and the percentage burrowed calculated. Behavioural data were analysed using one-way ANOVA with Brown-Forsythe test and Tukey's post hoc test. For behavioural testing no formal randomization was needed or used. Experimenter was blind to group allocation during all experiments and when assessing outcome. Novel object recognition memory. This was performed as described 12 . Briefly, mice were tested in a black cylindrical arena (69 cm diameter) mounted with a 100 LED strip infrared light source and a high resolution day/night video camera (Sony). Mice were acclimatized to the arena 5 days before testing. During the learning phase, two identical objects were placed 15 cm from the sides of the arena. Each mouse was placed in the arena by an operator blind to the experimental group for two blocks of 10 min for exploration of the objects with an inter-trial interval of 10 min.
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Two hours later, one of the objects was exchanged for a novel one, and the mouse was replaced in the arena for 5 min (test phase). The amount of time spent exploring all objects was tracked and measured for each animal using Ethovision software (Tracksys). All objects and the arena were cleansed thoroughly between trials to ensure the absence of olfactory cues. The amount of time spent exploring the novel object over the familiar object is expressed as a ratio, where a ratio of 1 reflects random exploration, and .1 reflects memory. Behavioural data were analysed using one-way ANOVA with Brown-Forsythe test and Tukey's post hoc test. For behavioural testing no formal randomization was needed or used. Experimenter was blind to group allocation during all experiments and when assessing outcome. Electrophysiology. Whole-cell recordings were made in acute hippocampal slices to measure synaptic transmission from identified CA1 neurons and recording performed as described 31 . In brief, neurons were voltage clamped using a Multiclamp 700B amplifier and pClamp 10.3 software (Molecular Devices) and EPSCs were evoked by stimulation with bipolar platinum electrode at 37 uC. Pipettes (2.5-3.5 MV) were filled with a solution containing (in mM): KCl 110, HEPES 40, EGTA 0.2, MgCl 2 1, CaCl 2 0.1; pH was adjusted to 7.2 with KOH. Neurons were visualized with 360 objective lenses on a Nikon FS600 microscope fitted with differential interference contrast optics. Four to eight cells were measured per mouse in at least two animals per experiment. Male mice were used to avoid effects of the oestrus cycle.
Hippocampal slice preparation and 35 S-methionine labelling. Slices were dissected in an oxygenated cold (2-5 uC) sucrose artificial cerebrospinal fluid (ACSF) containing (mm): 26mM NaHCO 3 , 2.5mM KCl, 4 mM MgCl 2 , 0.1 mM CaCl 2 , and 250mM sucrose. Hippocampal slices were prepared using a tissue chopper (McIlwain). Slices were allowed to recover in normal ACSF buffer while being oxygenated at 37 uC for 1 h, then incubated with [ 35 S]-methionine label for 1 h, then homogenized 14 . Proteins were TCA precipitated and incorporation of radiolabel was measured by scintillation counting (Winspectal, Wallac). Statistics. Statistical analyses were performed using Prism v5 software, using Student's t-test for data sets with normal distribution and a single intervention; when the F-test to compare variances was significant, Mann-Whitney U-test was performed instead.
Behavioural data, neuronal counts and 35 S-met were analysed using one-way ANOVA and Tukey's post hoc test for multiple variables.
For behavioural testing no formal randomization was needed or used. Experimenter was blind to group allocation during the experiments and when assessing outcome. Statistical analyses for in vivo experiments. Sample size estimation for induction of hypothermia for volume, synaptic density and estimation of total number of synapses was based in effect size of the preliminary experiment on dissector method (5.9511) and obtained with the free software G*Power version 3.1.9.2.
The software prediction shows that with a sample size of 6 animals for 2 conditions (control and cooled or cooled and rewarmed), the experiment has a 99.8% of chance of detecting a difference and avoid a type II error (b-error), with a 0.05% chance of a type I (a-error). Sample size estimation for novel object recognition experiment was established based on the effect size of 1.6161 from control and prion mice at 8 w.p.i. This parameter was applied in the following F tests calculation of power analysis with G*Power version 3.1.9.2.
Similar analyses were performed for burrowing tests. size to validate 2D assumption-based approaches for counting synapse density. a, CA1 volume and synapse mean length and area in the stratum radiatum remain essentially unchanged on cooling and rewarming in wild-type mice. Volume was measured using disector principle and synapse mean length and area determined in the same sections, as described 1 , n values as reported for Fig. 1a . b, c, Representative electron micrographs (pseudo-coloured for ease of synapse identification) for data not shown in Fig. 1b, c object testing is normal in all groups and RBM3 knockdown abolishes improved memory after cooling. a, Exploratory behaviour measured in seconds is not different in mice with early cooling from prion-diseased mice and is not affected by the duration of disease (n as reported in Fig. 3d ). b, c, Lentivirally mediated RNAi of RBM3 eliminates the protective effect of cooling on novel object memory impairment in prion disease (b) (dark green bar); but does not affect exploratory behaviour in training phase (c). All data represent means 6 s.e.m. Data analysed using one way ANOVA, Brown-Forsythe test with Tukey's post hoc analysis for multiple comparisons (n 5 11-16 mice per time point, **P , 0.01). impaired structural synaptic plasticity in the 5XFAD mouse model, and also reduced synapse number and function in wild-type mice. a, Impaired structural synaptic plasticity after cooling occurs in shRNA-RBM3 treated 5XFAD mice at 3 months. Representative electron micrographs are shown and are pseudo-coloured as in main text figures. Quantification shows significant reduction in synapse number by RNAi of RBM3 (n 5 82-93 images from 3 mice per time point, Student's t-test, two tailed). b, RBM3 knockdown reduces synapse number and novel object memory in wild-type mice (n 5 93 images from 3 mice per time point, Student's t-test, two tailed ***P , 0.0001; for novel object recognition task n 5 11 mice, LV-shRNA-control and 10 mice, LV-shRNA-RBM3, Mann-Whitney U-test, *P , 0.05). Scale bar, 1 mm.
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